Display options
Share it on

J Pharm Technol. 2017;33(4):156-166. doi: 10.1177/8755122517710671. Epub 2017 May 23.

Patterns of Statin Use in Older Medicare Beneficiaries With Traumatic Brain Injury.

The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians

Bilal Khokhar, Linda Simoni-Wastila, Julia F Slejko, Eleanor Perfetto, Min Zhan, Gordon S Smith

Affiliations

  1. University of Maryland, Baltimore, MD, USA.
  2. National Health Council, Washington, DC, USA.
  3. West Virginia University, Morgantown, WV, USA.

PMID: 29577114 PMCID: PMC5863738 DOI: 10.1177/8755122517710671

Abstract

BACKGROUND: In addition to lowering lipids, statins also may be beneficial for older adults sustaining a traumatic brain injury (TBI), as statin use prior to and following trauma may decrease mortality following injury. However, despite statins' potential to reduce mortality, there is limited research regarding statin use among older adults.

OBJECTIVE: To characterize and investigate factors associated with statin use among older adults with TBI.

METHODS: A retrospective drug utilization study was used to characterize statin use among Medicare beneficiaries 65 and older hospitalized with a TBI during 2006 to 2010 and with continuous Medicare Parts A, B, and D coverage 6 months prior and 12 months following TBI. Logistic regression was used to investigate the factors associated with statin use. The exposure of interest was statin use prior to and following TBI.

RESULTS: Of the 75 698 beneficiaries included in the study, 37 874 (~50%) of beneficiaries used a statin at least once during the study period. The most common statin used was simvastatin, while fluvastatin was the least used statin. Statin users were more likely to have cardiovascular diseases when compared to nonusers. Hyperlipidemia was a major factor associated with statin use and had the greatest impact on statin use compared to nonuse (odds ratio = 9.54; 95% confidence interval = 9.07, 10.03).

CONCLUSIONS: This national sample of older adults with TBI suggests that statins are commonly used. Future studies must next examine the impact of statin use on mortality and secondary injury in order to shape pharmacological therapy guidelines following TBI.

Keywords: cardiovascular drugs; drug utilization; geriatrics; pharmacoepidemiology; trauma medicine

Conflict of interest statement

Declaration of Conflicting Interests The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

  1. Health Aff (Millwood). 2009 Mar-Apr;28(2):w305-16 - PubMed
  2. J Am Coll Cardiol. 2008 Nov 25;52(22):1769-81 - PubMed
  3. J Trauma. 2011 Oct;71(4):815-9 - PubMed
  4. Neurotherapeutics. 2010 Jan;7(1):62-73 - PubMed
  5. Brain Inj. 2016;30(8):993-8 - PubMed
  6. Am J Geriatr Pharmacother. 2011 Dec;9(6):471-82 - PubMed
  7. PLoS Med. 2005 May;2(5):e123 - PubMed
  8. Ann Pharmacother. 2008 Sep;42(9):1208-15 - PubMed
  9. Clin Ther. 2006 Sep;28(9):1411-24; discussion 1410 - PubMed
  10. JAMA Intern Med. 2014 Aug;174(8):1244-51 - PubMed
  11. Brain Inj. 2013;27(13-14):1492-9 - PubMed
  12. Crit Care. 2013 May 29;17(3):227 - PubMed
  13. Handb Clin Neurol. 2015;127:343-66 - PubMed
  14. BMJ. 2009 Jun 30;338:b2376 - PubMed
  15. Nurs Crit Care. 2012 May-Jun;17(3):138-50 - PubMed
  16. Am J Cardiol. 2011 May 15;107(10):1409-14 - PubMed
  17. J Clin Med Res. 2013 Jun;5(3):168-73 - PubMed
  18. J Clin Psychiatry. 2016 Apr;77(4):505-11 - PubMed
  19. J Head Trauma Rehabil. 2015 Mar-Apr;30(2):E62-7 - PubMed
  20. Eur J Prev Cardiol. 2014 Apr;21(4):464-74 - PubMed
  21. J Trauma. 1996 Sep;41(3):380-6; discussion 386-8 - PubMed
  22. J Trauma. 2008 Jan;64(1):66-73; discussion 73-4 - PubMed
  23. J Am Coll Cardiol. 2013 Dec 24;62(25):2392-2394 - PubMed
  24. Am Heart J. 2008 Oct;156(4):662-73 - PubMed
  25. Arch Phys Med Rehabil. 2010 Jan;91(1):20-9 - PubMed

Publication Types

Grant support